Drug Trial Radar · NCT06519981
Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians
Last checked: Nov 20, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Aug 21, 2024
Primary completion
Sep 29, 2024
Study completion Nov 27, 2024
Sponsor
- Lead sponsor
- Atridia Pty Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 25, 2024
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase 1, randomized, double-blind, placebo-controlled study. The objective of this study is to evaluate the safety, tolerability, and PK profile of HRS-9231 injection following a single dose in healthy Caucasian participants.
Conditions
- MRI
Interventions
HRS-9231or matching placeboDrug
HRS-9231 injection or matching placebo will be administered through IV injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Day 8
- Vital signsTime frame: Day 8
- Physical examinationTime frame: Day 8
- LaboratoryTime frame: Day 8
- ECGTime frame: Day 8
- Injection site reactionTime frame: Day 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Linear Clinical research
Perth, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.